NGAL is the most extensively studied renal biomarker and it has been demonstrated in a recent meta-analysis that serum and urine NGAL levels have been found to be not only diagnostic of AKI, but that they have also predicted the clinical outcomes, such as the need for inititaion of dialysis, and mortality.25 Here, LCN2 is linked to acute kidney injury.